The T3-TR* / Comprehensive Case Management Programme (CCMP), inspired by the WHO’s “T3: Test.Treat.Track.” initiative, is an operational research platform that aims to assess the impact of universal access to diagnosis and treatment on malaria incidence in different transmission settings in Odisha, India. This multi-year collaborative initiative is being implemented by the NVBDCP Odisha in close collaboration with NIMR, with support from MMV and WHO.
The programme also aims to identify and address specific challenges in the radical cure of P. vivax malaria, strengthen the community level pharmacovigilance system, and assess the impact on operational indicators such as coverage, compliance, and access to care. Each project district comprises an intervention and a control “block” (an administrative subdivision of a district), without substantial contiguous areas, across four types of transmission settings and different ratios of P. falciparum/P. vivax malaria. Each block includes 100,000-150,000 people, and Accredited Social Health Activists (ASHAs) work at the community level to diagnose malaria, including P. vivax, with newly introduced bivalent RDTs, and treat patients in line with national treatment guidelines.